Kimberly-Clark ( KMB) beat second-quarter targets and reaffirmed full-year guidance. The Dallas-based tissue titan made $378 million, or 82 cents a share, for the quarter ended June 30, down from the year-ago $422 million, or 88 cents a share. Revenue rose 4.4% from a year ago to $4.16 billion. Excluding certain costs, latest-quarter earnings were 95 cents a share, a penny ahead of the Thomson Financial target. Sales of personal care products climbed 7.1% in the second quarter, driven primarily by sales volume growth of approximately 6%, along with currency benefits of 1%. Net selling prices were essentially even with the prior year. Sales of consumer tissue products increased 0.8% vs. the second quarter of 2005. Net selling prices went up approximately 4%, mainly as a result of aggressive price increases in North America and Europe, and favorable product mix contributed an additional 1%. These improvements, however, were mostly offset by volume declines in the two regions following the price increases. Sales of health care products increased 10.2% in the quarter. Sales volumes rose more than 7% on the strength of broad-based growth in face masks, sterilization wrap, medical devices and new Sterling Nitrile exam gloves. Favorable product mix benefited second-quarter sales by 2% and higher selling prices contributed an additional 1%. Kimberly-Clark said it remains comfortable with previous guidance that earnings per share before unusual items in 2006 will be in a range of $3.85 to $3.95. In the third quarter, price increases should continue to benefit the top line and, based on product initiatives, volume comparisons should improve vs. the second quarter. Earnings per share before unusual items will be somewhat better than the second quarter, in a range of 96 to 99 cents per share, in line with the 98-cent estimate.